Brief: Collegium Provides 2024 Financial Guidance

Collegium Pharmaceutical

03/01/2024 13:19

Jan 3 (Reuters) - Collegium Pharmaceutical Inc  COLL.O :
    * COLLEGIUM PROVIDES 2024 FINANCIAL GUIDANCE
    * $150.0 MILLION SHARE REPURCHASE PROGRAM AUTHORIZED BY
BOARD OF
DIRECTORS
    * ADJUSTED OPERATING EXPENSES EXPECTED IN RANGE OF $120.0
MILLION
TO $125.0 MILLION IN 2024
    * SEES FY24 PRODUCT REVENUES IN RANGE OF $580.0 MILLION TO
$595.0
MILLION

Source text for Eikon:  ID:nGNX89bk60 
Further company coverage:  COLL.O 

 ((Reuters.Briefs@thomsonreuters.com;))